# US 2021/0171995 A1 · Method for Using Electrochemical Bioreactor Module with Recovery of Cofactor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0171995 A1
- Document ID: US20210171995A1
- Status: Published application
- Kind: A1
- Application number: 17/182,039
- Filed: 2021-02-22
- Published: 2021-06-10
- Earliest claimed: 2016-03-14
- Assignees: Biocheminsights, Inc.
- Applicants: Biocheminsights, Inc.
- Inventors: Clifford S. Morrison; William B. Armiger; David R. Dodds; Mattheos Koffas
- Web page: https://patentgrep.com/patent/US20210171995A1

## CPC

- C12P 19/36: Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate
- A61K 31/7084: Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
- C07H 1/00: Processes for the preparation of sugar derivatives
- C07H 19/207: the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C12N 1/165: Yeast isolates
- C12N 1/185: Saccharomyces isolates
- C12N 1/205: Bacterial isolates
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/0008: {acting on the aldehyde or oxo group of donors (1.2)}
- C12N 9/0036: {acting on NADH or NADPH (1.6)}
- C12N 9/0059: {Catechol oxidase (1.10.3.1), i.e. tyrosinase}
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12P 19/32: having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
- C12Y 110/03001: Catechol oxidase (1.10.3.1), i.e. tyrosinase
- C12R 2001/11: Bacillus megaterium
- C12R 2001/125: Bacillus subtilis {; Hay bacillus; Grass bacillus}
- C12R 2001/15: Corynebacterium
- C12R 2001/19: Escherichia coli
- C12R 2001/84: Pichia
- C12R 2001/865: Saccharomyces cerevisiae
- C12Y 101/01: with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y 103/01: with NAD+ or NADP+ as acceptor (1.3.1)
- C12Y 113/11001: Catechol 1,2-dioxygenase (1.13.11.1)
- C12Y 114/11: with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
- H01M 8/16: Biochemical fuel cells, i.e. cells in which microorganisms function as catalysts
- Y02E 60/50: Fuel cells
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- H01M: PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

Provided herein are composition and process for using an electrochemical device for the reduction of the oxidized state of phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide to the reduced state in which unwanted products of the electrochemical reduction are recovered as the oxidized state of the phosphorylated or non-phosphorylated nicotinamide adenine dinucleotide and returned to the electrochemical device for reduction.

## Claims

### Claim 1

A system for electrochemically generating NAD(P)H2 reducing equivalents comprising:
an electrochemical cell comprising an anode contained in an anode chamber and a cathode contained in a cathode chamber;
a first process stream containing NAD(P), passing through the cathode chamber and continuously in contact with the cathode from which electrons are transferred to the NAD(P) to produce a second process stream containing reduced species 1,4-NAD(P)H2, 1,2-NAD(P)H2, 1,6-NAD(P)H2, and [NAD(P)]2, while optionally producing hydrogen;
a substrate of an oxidoreductase or P450 enzyme, which, when contacted with the second process stream in the presence of the oxidoreductase or P450 enzyme, is transformed to a product while concomitantly consuming the 1,4-NAD(P)H2 in the second process stream and producing a first recovered NAD(P) and a third process stream; and
at least one of a Mung Bean Phenol Oxidase enzyme and illumination at a wavelength of about 254 nm or exceeding about 320 nm, which, when contacted with the third process stream, convert at least one of the 1,2-NAD(P)H2, 1,6-NAD(P)H2, and [NAD(P)]2 therein to a second and optionally a third recovered NAD(P).

### Claim 2 (depends on 1)

The system of claim 1, comprising the Mung Bean Phenol Oxidase enzyme for converting the 1,2-NAD(P)H2, 1,6-NAD(P)H2, and/or [NAD(P)]2 into the second recovered NAD(P) and/or the third recovered NAD(P).

### Claim 3 (depends on 1)

The system of claim 1, comprising the illumination for converting the [NAD(P)]2 into NAD(P).

### Claim 4 (depends on 1)

The system of claim 1, comprising the Mung Bean Phenol Oxidase enzyme and the illumination.

### Claim 5 (depends on 4)

The system of claim 4, wherein the third process stream is contacted with the Mung Bean Phenol Oxidase enzyme resulting in conversion of the 1,2-NAD(P)H2 and 1,6-NAD(P)H2 into the second recovered NAD(P) and a fourth process stream, wherein the fourth process stream is contacted with the illumination to convert the [NAD(P)]2 therein to the third recovered NAD(P).

### Claim 6 (depends on 1)

The system of claim 1, further comprising, in one or more of the process streams, an electron transfer mediator (ETM) capable of transferring electrons to NAD(P).

### Claim 7 (depends on 1)

The system of claim 1, further comprising catalase for decomposing hydrogen peroxide produced by the Mung Bean Phenol Oxidase enzyme and/or the illumination.

### Claim 8 (depends on 2)

The system of claim 2, wherein the Mung Bean Phenol Oxidase enzyme is recombinantly expressed from microorganisms such as Escherichia coli, Bacillus subtilis, Corynebacterium glutamicum, Saccharomyces cerevisiae, Pichia pastoris, and Bacillus megaterium.

### Claim 9 (depends on 2)

The system of claim 2, wherein the Mung Bean Phenol Oxidase enzyme is a mutant form having a lower oxidation activity for 1,4-NAD(P)H2 than the wild type Mung Bean Phenol Oxidase enzyme, and/or a higher oxidation activity for 1,2-NAD(P)H2, 1,6-NAD(P)H2 and/or [NAD(P)]2 than the wild type Mung Bean Phenol Oxidase enzyme, wherein preferably the mutant form is recombinantly expressed from microorganisms such as Escherichia coli, Bacillus subtilis, Corynebacterium glutamicum, Saccharomyces cerevisiae, Pichia pastoris, and Bacillus megaterium.

### Claim 10

A method for electrochemically generating NAD(P)H2 reducing equivalents comprising:
a. providing an electrochemical cell comprising an anode contained in an anode chamber and a cathode contained in a cathode chamber;
b. passing through the cathode chamber a first process stream which contains NAD(P) and is continuously in contact with the cathode from which electrons are transferred to the NAD(P) to produce a second process stream containing reduced species 1,4-NAD(P)H2, 1,2-NAD(P)H2, 1,6-NAD(P)H2, and [NAD(P)]2, while optionally producing hydrogen;
c. contacting the second process stream with a substrate of an oxidoreductase or P450 enzyme such that the substrate, in the presence of the oxidoreductase or P450 enzyme, is transformed to a product while concomitantly consuming the 1,4-NAD(P)H2 in the second process stream and producing a first recovered NAD(P) and a third process stream; and
d. contacting the third process stream with at least one of a Mung Bean Phenol Oxidase enzyme and illumination at a wavelength of about 254 nm or exceeding about 320 nm, thereby converting at least one of the 1,2-NAD(P)H2, 1,6-NAD(P)H2, and [NAD(P)]2 therein to a second recovered NAD(P) and optionally a third recovered NAD(P).

### Claim 11 (depends on 10)

The method of claim 10, further comprising contacting the third process stream with the Mung Bean Phenol Oxidase enzyme for converting the 1,2-NAD(P)H2, 1,6-NAD(P)H2, and/or [NAD(P)]2 into the second recovered NAD(P) and/or the third recovered NAD(P).

### Claim 12 (depends on 10)

The method of claim 10, further comprising contacting the third process stream with the illumination for converting the [NAD(P)]2 into NAD(P).

### Claim 13 (depends on 10)

The method of claim 10, further comprising contacting the third process stream with the Mung Bean Phenol Oxidase enzyme resulting in conversion of the 1,2-NAD(P)H2 and 1,6-NAD(P)H2 therein into the second recovered NAD(P) and a fourth process stream, and further comprising contacting the fourth process stream with the illumination to convert the [NAD(P)]2 therein to the third recovered NAD(P).

### Claim 14 (depends on 10)

The method of claim 10, further comprising providing, in one or more of the process streams, an electron transfer mediator (ETM) capable of transferring electrons to NAD(P).

### Claim 15 (depends on 10)

The method of claim 10, further comprising providing catalase for decomposing hydrogen peroxide produced by the Mung Bean Phenol Oxidase enzyme, and/or the illumination.

### Claim 16 (depends on 10)

The method of claim 10, wherein the Mung Bean Phenol Oxidase enzyme is recombinantly expressed from microorganisms such as Escherichia coli, Bacillus subtilis, Corynebacterium glutamicum, Saccharomyces cerevisiae, Pichia pastoris, and Bacillus megaterium.

### Claim 17 (depends on 10)

The method of claim 10, wherein the Mung Bean Phenol Oxidase enzyme is a mutant form having a lower oxidation activity for 1,4-NAD(P)H2 than the wild type Mung Bean Phenol Oxidase enzyme, and/or a higher oxidation activity for 1,2-NAD(P)H2, 1,6-NAD(P)H2 and/or [NAD(P)]2 than the wild type Mung Bean Phenol Oxidase enzyme, wherein preferably the mutant form is recombinantly expressed from microorganisms such as Escherichia coli, Bacillus subtilis, Corynebacterium glutamicum, Saccharomyces cerevisiae, Pichia pastoris, and Bacillus megaterium.

### Claim 18 (depends on 10)

The method of claim 10, further comprising returning the third process stream to the cathode chamber.
